• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CIDRAP- NEWS BRIEFS February 19, 2026

Lance

MPH, CSP & CIT Retired, CHMM Emeritus
www.cidrap.umn.edu/all-news

Libya eliminates highly contagious bacterial eye infection



News brief

9 minutes ago.
Chris Dall, MA
Topics

Misc Emerging Topics

Libya has become the latest country to eliminate the world’s leading infectious cause of blindness.

The World Health Organization (WHO) said yesterday that Libya is the 28th country worldwide to officially eliminate trachoma, which is caused by the bacterium Chlamydia trachomitis. Trachoma spreads through personal contact with hands, clothing, or flies carrying infected eye discharge, and repeated infections can lead to scarring of the inner eyelid and blindness. It’s been documented in Libya for more than a century and remains endemic in many countries where access to water and sanitation is limited.

Libya’s Ministry of Health has prioritized trachoma elimination since 2017, aided by technical and operational support from the WHO. Libya’s acting minister of health said the achievement is a testament to the commitment of the country’s health workers.

“Even through difficult years, we maintained our focus on improving eye health services and ensuring no one was left behind,” Mohamed Al-Ghoj said in a WHO news release.

WHO officials said the achievement is notable given the country’s political instability, strained health services, and increased demand for basic services, including water, sanitation, and hygiene.

“This milestone reflects Libya’s determination to safeguard the health of its people and reinforces our conviction that progress against neglected tropical diseases is possible everywhere,” said WHO Director-General Tedros Adhanom Ghebreyesus, PhD.


Study highlights best antibiotic regimens for reducing infections after colorectal surgery


News brief

36 minutes ago.
Chris Dall, MA
Topics

Antimicrobial Stewardship
An analysis of more than 100 randomized clinical trials (RCTs) provides new insight into which antibiotic regimens are most effective at preventing surgical-site infection (SSI) following colorectal surgery, researchers reported today in JAMA Network Open.

The estimated incidence of SSI after elective colorectal surgery ranges from 10% to 25%, contributing to longer hospital stays for patients and increased use of antibiotics. While most international guidelines recommend dual-agent antibiotic prophylaxis prior to incision to reduce SSI risk, a variety of antibiotic combinations are used in clinical practice, and previous studies haven’t distinguished between antibiotic classes, a team led by researchers with McMaster University in Ontario noted.

“The optimal choice of antibiotic prophylaxis in elective colorectal surgery remains uncertain, with most reviews emphasizing timing and route of administration rather than direct comparisons of antibiotic classes,” they wrote.

The systematic review and meta-analysis examined 105 RCTs involving 18,273 patients undergoing elective colorectal surgery to determine which antibiotic prophylactic regimens are associated with the lowest risk of SSI. Thirty-day mortality, adverse events, and length of hospital stay were secondary outcomes. A total of 32 distinct antibiotic regimens were evaluated across the RCTs.

Evidence base for future guidance


High-to-moderate certainty evidence indicated that, compared with compared placebo or no antibiotics, several regimens were associated with reduced risk of SSI, but broad-spectrum penicillins and third-generation cephalosporins were associated with the most substantial reduction (74% and 73%, respectively). Broad-spectrum penicillins were also associated with a 79% decrease in 30-day mortality. No significant differences were observed between antibiotic classes regarding length of hospital stay or adverse events.

The authors say the analysis “provides a more clinically meaningful perspective than prior reviews that focused primarily on route of administration.”

“These findings highlight the importance of antibiotic class selection in prophylactic strategies and provide an evidence base to guide future guideline updates and clinical practice,” they wrote.

ALL BRIEFS
 
Back
Top Bottom